First In-vivo Trial of the Liver Percutaneous Isolated Localized Perfusion (PILP) Set for the Treatment of Liver Metastases
The objective of this Medical Device Study, is to demonstrate the feasibility of the liver
PILP intervention.
The liver PILP intervention will be considered feasible if the procedure is demonstrated to
be safe and the liver PILP kit performs according to specifications.
Interventional
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label
To demonstrate the feasibility of the liver PILP intervention.
The liver PILP intervention will be considered feasible if the intervention is demonstrated to be safe and the PILP kit performs according to specifications related to localization, flow rates and retrieval of devices.
During intervention and up to 30 days post intervention
Yes
Eric Van Cutsem, Prof MD PhD
Principal Investigator
University Hospitals Leuven, Catholic University
Belgium: Federal Agency for Medicines and Health Products, FAMHP
CIP 000369
NCT01250158
September 2010
Name | Location |
---|